Who invested in ADmit Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$6.1Mraised across 1 round since 2023, from 1 source

Latest round: Venture, $6.1MJul 2023
Investors: 3

See who backed them

The rounds

Jul 2023
Venture$6.1M
Source recorded

Founders and team

From ADmit Therapeutics's own website: 9 on the team.

Marta BarrachinaCEO
Alfred Fu Kong LuiLaboratory Director
Ferran PratChairman of the Board
Howard FillitBoard Member – Observer
Jose Luis MosqueraDirector of Artificial Intelligence and Data Science Department
Maite FiblaBoard Member
Miguel ViribayBusiness Development Director
Santiago LozanoBoard Member
Víctor FuentesQuality Manager

AdvisersCourosh MehanianJordi GascónRamón ReñéRussell Swerdlow

Everyone who backed them

EIC AcceleratorGovernment1round

Genesis VenturesVC firm1round

Clave CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list ADmit Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.